Advertisement
Advertisement
U.S. markets close in 1 hour 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Sintx Technologies, Inc. (SINT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.27000.0000 (0.00%)
As of 2:32PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close1.2700
Open1.2800
Bid1.2600 x 1300
Ask1.2700 x 900
Day's Range1.2600 - 1.3000
52 Week Range1.2200 - 3.4400
Volume63,436
Avg. Volume1,236,709
Market Cap31.373M
Beta (5Y Monthly)2.11
PE Ratio (TTM)N/A
EPS (TTM)-0.4740
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SINT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SiNtx Technologies, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is a diversified healthcare company that develops, manufactures and markets products in three primary lines of business: Pharmaceuticals, Medical Devices and Diagnostics, and Consumer Products.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    SINTX Technologies Shares Q3 2021 Revenue Update

    SALT LAKE CITY, Oct. 14, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today preliminary Q3 2021 revenue results and expectation of new Q4 2021 revenue from open orders of advanced ceramics prototypes. Estimated revenue in Q3 2021 was approximately $240k which is more than the revenue in each of Q1 and Q2 2021. Revenue came from three business areas, including monolit

  • GlobeNewswire

    SINTX Technologies Ships New FleX SN Porous and Laser-textured Spinal Implants

    SINTX Technologies, Inc. An example of a porous and textured Flex SN surface. SALT LAKE CITY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today that it has shipped production quantities of a new porous, laser-textured monolithic silicon nitride implant made of FleX SN (sintx.com/materials/flex) to be used in surgical spinal solutions. The shipment is the re

  • GlobeNewswire

    National Institute of Health Awards SINTX Technologies Phase 1 Grant for SN-PEEK 3D Printed Spinal Implants

    SALT LAKE CITY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant. This U.S. government funded research grant addresses the antibacterial and osseointegrative properties of silicon

Advertisement
Advertisement